14. Stability of permitted medications for 4 weeks prior to baseline. NOTE: Cholinesterase inhibitors and or memantine are allowable only if stable for 12 weeks prior to screen. If taking Aricept (donepezil), no more than 10 mg/day is permitted during the course of the study.